IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Torres, P. F.
Right arrow Articles by de Vos, A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Torres, P. F.
Right arrow Articles by de Vos, A. F.
(Investigative Ophthalmology and Visual Science. 1999;40:3194-3201.)
© 1999 by The Association for Research in Vision and Ophthalmology, Inc.

Changes in Cytokine mRNA Levels in Experimental Corneal Allografts after Local Clodronate–Liposome Treatment

Paulo F. Torres1,2,3, Tanja P. A. M. Slegers3, Ron Peek3, Nico van Rooijen4, Ruth van der Gaag3, Aize Kijlstra3,5 and Alex F. de Vos3

1 From the Department of Ophthalmology, Cornea and Immunology Unit, Hospital Geral de Santo António, Porto, Portugal; the 2 Department of Ophthalmology, Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Portugal; the 3 Department of Ophthalmo-Immunology, Netherlands Ophthalmic Research Institute, Amsterdam, the Netherlands; the 4 Department of Cell Biology, Free University, Amsterdam, the Netherlands; and the 5 Department of Ophthalmology, University of Amsterdam.

PURPOSE. Corneal allograft rejection in rats can be prevented by subconjunctival injections of liposomes containing dichloromethylene diphosphonate (clodronate–LIP), which selectively eliminate macrophages. In this study, the effect of clodronate–LIP treatment on cytokine mRNA levels in corneal allografts was examined.

METHODS. AO rats received corneal grafts of PVG rats. Rats were either not treated or injected subconjunctivally with clodronate–LIP on the day of transplantation and on postoperative days (PODs) 2, 4, 6, and 8. RNA was isolated from the graft and rim of corneas at different times after transplantation and from normal controls. Interleukin (IL)-1ß, IL-1 receptor antagonist (IL-1RA), IL-2, IL-4, IL-6, IL-10, IL-12p40, tumor necrosis factor (TNF)-{alpha}, TNF-ß/lymphotoxin (LT), interferon (IFN)-{gamma}, monocyte chemotactic protein 1 (MCP-1), and macrophage inflammatory protein 2 (MIP-2) mRNA levels were analyzed by semiquantitative reverse transcription–polymerase chain reaction (RT–PCR).

RESULTS. Corneal rejection, observed in all untreated rats by POD 12, was associated with increased mRNA levels of all cytokines investigated in grafts and rims. Clodronate–LIP treatment prevented allograft rejection and strongly decreased the levels of IL-1ß, IL-1RA, IL-2, IL-4, IL-6, IL-10, IFN-{gamma}, TNF-ß/LT, MCP-1, and MIP-2 mRNA in grafts and IL-1 ß, IL-2, IL-4, IL-6, and IFN-{gamma} mRNA in rims. Interleukin-12p40 mRNA levels were unaltered in clodronate-treated rats, except for a transient increase in grafts at POD 3. TNF-{alpha} mRNA levels were increased by clodronate–LIP in grafts and rims early after transplantation (PODs 3 and 7). Despite a normal appearance, long-term accepted corneal grafts (POD 100) contained mRNA for IL-10, IL-12p40, TNF-{alpha}, MCP-1, and MIP-2.

CONCLUSIONS. Clodronate-liposome treatment markedly altered the mRNA levels of all cytokines investigated in corneal allografts. These results may explain in part the mechanism by which clodronate–LIP treatment prevents corneal allograft rejection.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Klebe, D. J. Coster, P. J. Sykes, S. Swinburne, P. Hallsworth, J.-P. Y. Scheerlinck, R. Krishnan, and K. A. Williams
Prolongation of Sheep Corneal Allograft Survival by Transfer of the Gene Encoding Ovine IL-12-p40 but Not IL-4 to Donor Corneal Endothelium
J. Immunol., August 15, 2005; 175(4): 2219 - 2226.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. Yamada, K. Maruyama, Y. Sano, S. Kinoshita, Y. Murata, and J. Hamuro
Promotion of Corneal Allograft Survival by the Induction of Oxidative Macrophages
Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 448 - 454.
[Abstract] [Full Text] [PDF]


Home page
J Biomater ApplHome page
R. Banerjee
Liposomes: Applications in Medicine
J Biomater Appl, July 1, 2001; 16(1): 3 - 21.
[Abstract] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
Y. Sekine, K. Yasufuku, K. M. Heidler, O. W. Cummings, N. Van Rooijen, T. Fujisawa, J. Brown, and D. S. Wilkes
Monocyte Chemoattractant Protein-1 and RANTES Are Chemotactic for Graft Infiltrating Lymphocytes during Acute Lung Allograft Rejection
Am. J. Respir. Cell Mol. Biol., December 1, 2000; 23(6): 719 - 726.
[Abstract] [Full Text]


Home page
IOVSHome page
T. P. A. M. Slegers, P. F. Torres, L. Broersma, N. van Rooijen, G. van Rij, and R. van der Gaag
Effect of Macrophage Depletion on Immune Effector Mechanisms during Corneal Allograft Rejection in Rats
Invest. Ophthalmol. Vis. Sci., July 1, 2000; 41(8): 2239 - 2247.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Association for Research in Vision and Ophthalmology